Altogether, these studies have identified different mechanisms by which Th17 cells are controlling tumor growth as follows: recruitment of several immune cells including DCs, CD4+ T cells, and CD8+ T cells within tumors, activation of CD8+ T cells, and possibly plasticity toward Th1 phenotype, associated with IFN-γ and TNF-α production. The gene discussed is IFNG; the disease is neoplasm.